Thomas Oxley

SmartStent Pty Ltd. develops medical technology for vascular bionics. The firm offers STENTRODE, a stent-based electrode array that is implanted by cerebral angiography. This minimally invasive day procedure will allow access to areas of the brain that control the movement of limbs, without having to perform open brain surgery. The company was founded by Thomas Oxley on November 30, 2012 and is headquartered in Melbourne, Australia.

Synchron, Inc. operates as a medical device company that develops neural interface technology. It offers Stentrode, an endovascular electrode array. The company was founded by Thomas Oxley and Nicholas Opie and is headquartered in Campbell, CA.

SmartStent Pty Ltd. develops medical technology for vascular bionics. The firm offers STENTRODE, a stent-based electrode array that is implanted by cerebral angiography. This minimally invasive day procedure will allow access to areas of the brain that control the movement of limbs, without having to perform open brain surgery. The company was founded by Thomas Oxley on November 30, 2012 and is headquartered in Melbourne, Australia.

Synchron, Inc. operates as a medical device company that develops neural interface technology. It offers Stentrode, an endovascular electrode array. The company was founded by Thomas Oxley and Nicholas Opie and is headquartered in Campbell, CA.

SmartStent Pty Ltd. develops medical technology for vascular bionics. The firm offers STENTRODE, a stent-based electrode array that is implanted by cerebral angiography. This minimally invasive day procedure will allow access to areas of the brain that control the movement of limbs, without having to perform open brain surgery. The company was founded by Thomas Oxley on November 30, 2012 and is headquartered in Melbourne, Australia.

Synchron, Inc. operates as a medical device company that develops neural interface technology. It offers Stentrode, an endovascular electrode array. The company was founded by Thomas Oxley and Nicholas Opie and is headquartered in Campbell, CA.

Synchron, Inc. operates as a medical device company that develops neural interface technology. It offers Stentrode, an endovascular electrode array. The company was founded by Thomas Oxley and Nicholas Opie and is headquartered in Campbell, CA.

Synchron, Inc. operates as a medical device company that develops neural interface technology. It offers Stentrode, an endovascular electrode array. The company was founded by Thomas Oxley and Nicholas Opie and is headquartered in Campbell, CA.